# Evaluation of Progression of Myopia in Children Treated With Vitamin B2 and Outdoor Sunlight Exposure

> **NCT03552016** · PHASE2 · SUSPENDED · sponsor: **University of Missouri-Columbia** · enrollment: 100 (estimated)

## Conditions studied

- Axial Myopia
- Refractive Errors

## Interventions

- **DRUG:** Oral Riboflavin

## Key facts

- **NCT ID:** NCT03552016
- **Lead sponsor:** University of Missouri-Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2018-10-10
- **Primary completion:** 2029-10-10
- **Final completion:** 2030-10-10
- **Target enrollment:** 100 (ESTIMATED)
- **Why stopped:** Lack of funds and move of all investigators to other institutions.
- **Last updated:** 2024-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03552016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03552016, "Evaluation of Progression of Myopia in Children Treated With Vitamin B2 and Outdoor Sunlight Exposure". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03552016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*